Thrombosis in Cancer Patients Treated with Hematopoietic Growth Factors - A Meta-Analysis

Keywords

Medicine, Thrombosis, Cancer, Intensive care medicine, Neutropenia

References

• A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.NJ Chao, JR Schriber, GD Long — 1994
• Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin DiseaseSubhash C. Gulati, Charles L. Bennett — 1992
• Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as an Adjunct to Autologous Hemopoietic Stem Cell Transplantation for LymphomaRanjana H. Advani, Nelson J. Chao, Sandra J. Horning — 1992
• Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer.Andrea Ardizzoni, M. Venturini, M.R. Sertoli — 1994
• Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high‐dose chemotherapy plus granulocyte‐macrophage colony‐stimulating factor a randomized trialA. Kritz, John Crown, Robert J. Motzer — 1993
• Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects.Ronald M. Bukowski, S. Murthy, Denise McLain — 1993
• A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.Kenji Eguchi, Hisashi Etou, Sumiki Miyachi — 1994
• Acute arterial thrombosis after escalated‐dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony‐stimulating factor: A possible new recombinant granulocyte colony‐stimulating factor toxicityJohn A. Conti, Howard I. Scher — 1992
• Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial.R Powles, C. W. Smith, J. Treleaven — 1990
• Granulocyte‐macrophage colony‐stimulating factor increases dose intensity of chemotherapy in small cell lung cancer: Relationship between clinical results, peripheral blood cell modifications, and bone marrow kineticsAdriano Paccagnella, Adolfo Favaretto, Alberto Riccardi — 1993
• Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF)A. Lindemann, Brigitta Rumberger — 1993
• Granulocyte colony-stimulating factor and platelet aggregation.Kazuyka Shimoda, Seiichi Okamura, Syoichi Inaba — 1993
• Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer.Cesare Gridelli, Sabino De Placido, Rosario Pepe — 1993
• Complications of indwelling venous access devices in cancer patients.Brian J. Eastridge, Alan Kawarai Lefor — 1995
• Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils.Judith C. Gasson, Richard H. Weisbart, Susan Kaufman — 1984
• Statistical aspects of the analysis of data from retrospective studies of disease.Nathan Mantel, William Haenszel — 1959
• Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever.Bonne Biesma, Elisabeth G.E. de Vries, Pax H.B. Willemse — 1990
• Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.N Masuda, M. Fukuoka, Satoshi Kudoh — 1994
• Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer.David Miles, O Fogarty, C. M. Ash — 1994
• Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma.Jean L. Grem, Nanette McAtee, Robert F. Murphy — 1994

Cited by

• Adverse effects on hemostatic function of drugs used in hematologic malignancies.俊治 目黒 — 2007
• Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor.Anna Falanga, Marina Marchetti, Virgilio Evangelista — 1999
• Venous thromboembolism in patients with cancer undertaking chemotherapyA. Rahman — 2015
• Effects of Recombinant Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor on Platelet Aggregation in Healthy VolunteersCengiz Zeybek, Orhan Gürsel, Abdullah Avni Atay — 2015
• Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational studyAlok A. Khorana, Charles W. Francis, Eva Culakova — 2005
• Thrombotic and necrotizing panniculitis associated with recombinant human granulocyte colony‐stimulating factor treatmentO Dereure, D. Bessis, T. Lavabre-Bertrand — 2000
• Prevention of Thrombotic Disorders in Cancer Patients Undergoing ChemotherapyMark N. Levine — 1997
• A case of paraneoplastic pemphigus with antidesmoglein 1 antibodies as determined by immunoblottingPhilippe Martel, D. Gilbert, B. Labeille — 2000
• Colony-stimulating factors for chemotherapy-induced febrile neutropenia.Rahul Mhaskar, O Clark, Gary H. Lyman — 2014
• Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.O Clark, Gary H. Lyman, Aldemar Araújo Castro — 2005
• Cancer-associated thrombosis.Bruce Furie, Bruce Furie, Barbara C. Furie — 2006
• Venous thromboembolism in cancer patientsSnehal Sunil Sawant, Aditi Dhir, Anuprita Daddi — 2012
• Epidemiology of Thrombosis in CancerFrederick R. Rickles, Mark N. Levine — 2001
• Pathogenesis of Thrombosis in Patients with MalignancyAnna Falanga, Maria Benedetta Donati — 2001
• Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factorGiuseppe Cella, Marina Marchetti, A. Vignoli — 2006
• Pathogenetic Mechanisms of Thrombosis in MalignancyMaria Benedetta Donati, Anna Falanga — 2001
• A hanging mass in the ascending aorta diagnosed by transthoracic echocardiography in a totally asymptomatic subject.Umberto Baldini, Francesca Chiaramonti, Gaetano Minzioni — 2009
• Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practiceRoberto Castelli, Antonino Cannavò, Fabio Conforti — 2012
• Erythropoiesis stimulating agents, thrombosis and cancer.Lisa Barbera, Gillian Thomas — 2010
• Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.Eileen Danaher Hacker, Carol Estwing Ferrans, Ellen Verlen — 2006

Related papers

• A compatision between one visit RCT and several visit RCT for cracked teeth.Jin Xue-me — 2007
• Randomized Controlled Trials for Creating Scientific Evidence of the Efficacy and Safety of Complementary and Alternative MedicineToshiro Tango — 2004
• Practice and Educational Effects of a Simulated Randomized Controlled Trial for Acupuncture School TeachersTomoyuki Nabeta, Rina Kobayashi, Yoshihisa Kojima — 2010
• Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropeniaPranatharthi Chandrasekar, Bhawna Sirohi, Nita L. Seibel — 2018
• Basical Clinical Observation of Cracked Tooth with One visit RCTYang Hua-wei — 2003
• Randomized controlled drug trials on very elderly subjects: descriptive and methodological analysis of trials published between 1990 and 2002 and comparison with trials on adults.J.-L. Le Quintrec, Caroline Bussy, Jean Louis Golmard — 2005
• Ocular Randomized and Quasi-randomized Contral Trial in Ophthalmologic JournalsWu Xiaomei, Tang Jian, Weiming He — 2003
• Current situation on the reporting quality of randomized controlled trials in 5 leading Chinese medical journalsXü, Wei, Li — 2009